Gene Query: CALB1

Dataset Description Geneva Score
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 172.5
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 84.18
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 81.79
U2AF1 mutations alter splice site recognition in hematological malignancies 72.53
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 68.78
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 66.01
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 61.98
Transcriptome sequencing of K-562 cells 58.63
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 55.94
RNA sequencing analysis of human embryonic stem cells and axial progenitors 54.43
Ectoderm specification of H1 human embryonic stem cells 53.56
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 52.85
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 52.49
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 48.22
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 48.16
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 47.29
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 45.95
Depicting early human development and germ cell origin with porcine embryos 45.79
Maturation of human iNSCs 45.74
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 44.82
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 43.51
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 43.51
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 43.33
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 43.33
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 42.86
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 42.12
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 41.6
Lineage specific differentiation is influenced by state of human pluripotency 41.36
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 41.36
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 40.47
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 40.2
RNA-Seq from early time points in the kidney differentiation protocol 39.2
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 36.61
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 36.3
Differentially expressed genes post knock down of lincDUSP26 36.05
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 35.53
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 35.25
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 35.13
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 35.13
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 34.6
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 34.41
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 34.16
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 33.55
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 33.52
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 33.12
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 32.66
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 32.65
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 32.57
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 32.52
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 32.41
Differentially expressed vascular development genes for iPSC-ECs from CDI 32.39
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 31.9
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 31.63
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 31.18
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 30.64
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 30.34
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 30.26
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 29.85
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 28.93
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 28.47
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 28.44
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 28.41
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 28.34
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 28.34
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 28.0
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 27.9
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 27.9
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 27.83
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 27.83
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 27.34
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 27.13
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 26.96
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 26.82
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 26.82
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 26.8
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 26.08
RNA sequencing of human mammary epithelial cells 24.97
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 24.72
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 24.66
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 24.66
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 24.41
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 24.4
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 24.34
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 24.28
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 24.1
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 23.95
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 23.12
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 23.06
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 23.06
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 22.85
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 22.85
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 22.64
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 22.64
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 22.59
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 22.51
JunB control of keratinocyte-mediated inflammation [RNA-seq] 22.49
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 22.49
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 22.3
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 22.29
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 21.86
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 21.78
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 21.74
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 21.53
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 21.52
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 21.44
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 21.41
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 21.41
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 21.1
Dynamic reorganization of nuclear architecture during human cardiogenesis 20.77
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 20.77
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 20.68
In situ CAPTURE of chromatin interactions by biotinylated dCas9 20.65
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 20.65
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 20.59
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 20.18
RNA seq analysis of human Fetal and adult derived Enterospheres 19.95
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 19.38
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 19.28
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 19.14
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 19.14
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 18.91
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 18.79
Transcriptome analysis of kidney organoids 18.72
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 18.57
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 18.52
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 18.42
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 18.35
iPSC-Derived Cholangiocytes 18.08
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 18.07
PNET animal model: new insights (II) 18.06
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 17.98
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 17.72
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 17.66
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 17.41
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 17.41
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 17.41
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 17.35
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 17.24
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 17.24
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 17.17
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 16.78
Gene expression profile difference among renal location in a stone former 16.77
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 16.69
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 16.47
Derivation and differentiation of haploid human embryonic stem cells 16.32
BI Human Reference Epigenome Mapping Project 16.28
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 16.26
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 16.26
Regionally specified human pluripotent stem cell-derived astrocytes 16.14
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 16.05
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 16.02
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 15.96
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 15.94
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 15.94
Postnatal lipids drive hepatocyte maturation 15.86
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 15.85
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 15.85
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 15.8
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 15.78
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 15.52
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 15.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 15.25
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 15.16
RNA-seq analysis of RALD iPSCs after in vitro differentiation 14.7
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 14.55
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 14.42
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 14.37
RNA-seq analysis of gene expression patterns during hESC neural differentiation 14.17
hESC neural differentiation 14.17
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 14.16
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 14.16
RNA-seq analyses of human prostate cancer cells 14.15
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 14.12
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 13.93
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 13.89
Next Generation Sequencing of human SMA and healthy control Motor Neurons 13.49
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 13.39
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 13.39
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 13.32
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 13.27
High level DNA repair gene expression in human ES cells 13.09
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 12.97
High-efficiency RNA-based reprogramming of human primary fibroblasts 12.86
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.73
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 12.61
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 12.6
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 12.26
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 12.26
Role of FGFR1 in neuronal devlopment 12.22
Hypoxic transcriptome of SQ20B human head and neck cancer cells 12.22
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 12.22
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 11.89
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 11.63
Spliceosomal disruption of the non-canonical BAF complex in cancer 11.62
RNA-seq analysis of the human fetal kidney. 11.54
Accurate annotation of human protein-coding small open reading frames 11.47
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 11.42
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 11.4
FBXW7 modulates stress response by post-translational modification of HSF1 11.38
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 11.38
Zika virus directly infects human peripheral neurons and induces cell death 11.31
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 11.05
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 10.97
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 10.94
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 10.91
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 10.84
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 10.69
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.56
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 10.55
High-throughput sequencing of pluripotent cells 10.52
MEIS1 regulates hematopoiesis in hPSCs 10.42
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 10.26
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 10.09
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 10.02
The effect of Abl kinases on non-small cell carcinoma global transcriptome 9.87
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 9.61
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 9.48
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 9.42
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 9.42
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 9.31
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 9.27
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 9.23
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.2
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.2
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 9.19
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 9.19
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 9.13
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 9.1
Engineering Patient-Specific Tissue Implants 8.94
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.86
Cerebellar differentiation in Ataxia-Telangiectasia 8.79
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 8.78
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 8.78
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 8.66
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.63
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 8.51
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 8.47
RNAseq Study in CC-671 Treated Cal-51 Cells 8.45
Transcriptome analysis of H9 hESC derived cerebral organoids 8.4
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 8.25
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 8.25
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 8.22
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 8.22
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 8.22
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 8.07
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 8.06
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.92
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 7.92
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 7.88
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 7.85
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 7.82
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 7.75
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 7.63
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 7.62
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 7.53
In vitro modeling of human germ cell development using pluripotent stem cells 7.51
Glioblastoma stem cells infected by ZIKA virus 7.43
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.42
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 7.4
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 7.4
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 7.39
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 7.37
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 7.36
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 7.36
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 7.35
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.23
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 7.2
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 7.2
RNA splicing alteration on glioblastoma and normal neural stem cells 7.19
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 7.15
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 7.15
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 7.07
Non-coding regions are the main source of tumor-specific antigens [human] 7.04
Non-coding regions are the main source of tumor-specific antigens 7.04
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 6.93
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 6.93
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 6.92
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 6.92
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.89
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 6.83
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 6.83
RNA-seq analysis of breast cancer 6.77
RNA-seq analysis and shRNA screen of breast cancer 6.77
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 6.75
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 6.63
Global epigenomic reconfiguration during mammalian brain development 6.62
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 6.59
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 6.54
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.48
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 6.46
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 6.42
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.34
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 6.33
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 6.33
FGF2 regulation of gene expression in stable inducible Neurons 6.32
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 6.3
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 6.3
Reassessment of Exosome Composition 6.26
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 6.24
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 6.14
RNA sequencing of mechanically strained NHEKs and control NHEKs 6.12
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.11
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.11
Persistence of stem cell metabolism in cancers as a failure of differentiation 6.1
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 6.03
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.87
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 5.81
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 5.81
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 5.79
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 5.77
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 5.66
BAF controls genome accessibility 5.61
mRNA sequencing of oropharyngeal cancer cell lines 5.55
Epigenome regulation during epidermal lineage commitment [RNA-seq] 5.55
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 5.53
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 5.46
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.44
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 5.42
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.4
Expression profiles of the four human major ectodermal lineages 5.38
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 5.35
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 5.35
RNA-seq of naive and primed ES cells 5.24
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.11
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 4.98
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.94
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.84
4.83
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.8
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 4.77
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.76
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 4.74
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.73
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 4.71
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 4.7
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 4.7
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 4.7
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.69
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 4.66
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 4.66
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.66
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.63
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.63
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.61
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.5
Investigate A2M treatment on human prostate cancer xenograft in mice 4.48
Investigate A2M treatment on human prostate cancer and mouse liver 4.48
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 4.45
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.41
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 4.37
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 4.32
RNA sequencing of primary human platelets and in vitro cell lines 4.27
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.26
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.26
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 4.24
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 4.14
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 4.14
RNA-Seq of the corpus callosum from 12 individuals 3.99
Gene expressions of H9s in different culture systems 3.91
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 3.87
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 3.87
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 3.82
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 3.82
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 3.81
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.74
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 3.64
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 3.64
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.62
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.62
SLIGRL-induced gene expression changes in NHEK cells 3.6
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 3.55
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.47
Molecular Criteria for Defining the Naive Human Pluripotent State 3.46
Exploring the RNA landscape of endothelial exosomes 3.46
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.45
mRNA-Seq profiling of human developing kidney 3.36
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 3.28
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 3.26
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 3.22
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 3.17
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 3.17
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.02
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 2.98
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.96
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.95
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.87
Illumina Total RNA-seq in HeLa 2.84
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 2.82
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.78
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.77
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  2.66
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.64
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 2.62
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.47
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.45
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.42
The expression profiles of GBC liver metastasis 2.33
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.27
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.21
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.15
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.12
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.11
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.11
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 2.1
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.08
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.01
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.99
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.93
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.93
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.9
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.86
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.86
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.82
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.77
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.76
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.69
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.69
Repurposing of promoters and enhancers during mammalian evolution 1.68
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.65
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.65
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.61
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.59
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.54
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.54
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.54
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.53
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.48
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.43
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.4
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.37
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.33
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.31
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.3
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.29
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.24
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.24
Transcriptome of EBV-infected gastric cancer cell lines 1.23
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.21
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.19
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 1.19
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.19
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.19
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 1.13
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.12
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 1.12
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.1
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.04
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.03
RNA-Seq of Breast and Ovarian Cancer Cell Lines 1.02
ML29755 RNA-seq data 0.99
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.99
Epigenomic conservation of transposable element silencing [RNA-seq] 0.97
Epigenomic conservation of transposable element silencing 0.97
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.86
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.84
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 0.83
RNA sequencing of human pancreatic cancer cell lines 0.76
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.74
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.73
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.72
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 0.71
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.68
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.68
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.68
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.67
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.57
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.54
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.51
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.51
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.51
Multiple sclerosis and EAE 0.49
Human optic chiasm from healthy controls and multiple sclerosis patients 0.49
Gene expression of collecting duct carcinoma of the kidney 0.46
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 0.42
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.41
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.41
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.27
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.26
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.26
AMPK signaling for naïve pluripotency 0.26
AMPK signaling for naïve pluripotency [Hs] 0.26
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 0.23
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 0.23
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.21
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.2
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.19
Identification of expressed and conserved human non-coding RNAs 0.18
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.18
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.16
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.15
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.14
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.13
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.1
Transcriptional landscape changes during human embryonic stem cell derivation 0.09
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.08
Transcriptomic profiling of human peripheral blood-derived mast cells 0.08
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.04
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.01
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation